{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:04:39Z","timestamp":1791126279900,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.expneurol.2012.05.022","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T22:55:29Z","timestamp":1339800929000},"page":"36-42","source":"Crossref","is-referenced-by-count":35,"title":["Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?"],"prefix":"10.1016","volume":"237","author":[{"given":"Hanna S.","family":"Lindgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah J.","family":"Lelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Dunnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.05.022_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","article-title":"Long-term polarization of microglia upon alpha-synuclein overexpression in nonhuman primates","volume":"208","author":"Barkholt","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/nbdi.1997.0151","article-title":"Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease","volume":"4","author":"Bjorklund","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-5-42","article-title":"Fcgamma receptors are required for NF-kappaB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease","volume":"5","author":"Cao","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0035","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0040","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbr.2010.04.012","article-title":"Graft-mediated functional recovery on a skilled forelimb use paradigm in a rodent model of Parkinson's disease is dependent on reward contingency","volume":"212","author":"Cordeiro","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0065","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awr149","article-title":"GDNF fails to exert neuroprotection in a rat alpha-synuclein model of Parkinson's disease","volume":"134","author":"Decressac","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.expneurol.2012.05.022_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","article-title":"Comparison of the behavioural and histological characteristics of the 6-OHDA and alpha-synuclein rat models of Parkinson's disease","volume":"235","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/neu.10094","article-title":"Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP","volume":"53","author":"Dong","year":"2002","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainresbull.2005.08.009","article-title":"The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum","volume":"68","author":"Dowd","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0014-4886(03)00139-0","article-title":"Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys","volume":"183","author":"Eslamboli","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0085","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/brain\/awl382","article-title":"Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain","volume":"130","author":"Eslamboli","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0090","first-page":"693761","article-title":"Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD","volume":"2011","author":"Esteves","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1196\/annals.1369.032","article-title":"Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures","volume":"1074","author":"Fulceri","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in Parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00001756-200201210-00019","article-title":"Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector","volume":"13","author":"Georgievska","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(02)00091-X","article-title":"Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice","volume":"24","author":"Gomez-Isla","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0120","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jnr.22331","article-title":"Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior","volume":"88","author":"Graham","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0125","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1126\/science.8091209","article-title":"The basal ganglia and adaptive motor control","volume":"265","author":"Graybiel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2005.01.013","article-title":"Oxidative stress and inflammation in Parkinson's disease: is there a causal link?","volume":"193","author":"Hald","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410270405","article-title":"Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease","volume":"27","author":"Halliday","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0091-3057(80)90353-6","article-title":"Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA","volume":"12","author":"Hefti","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0145","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0150","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.conb.2011.10.016","article-title":"Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder","volume":"21","author":"Imai","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(76)90042-X","article-title":"Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions","volume":"37","author":"Iwamoto","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0170","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.0953-816x.2001.01534.x","article-title":"Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease","volume":"13","author":"Kirik","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0180","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0160","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"Kirik","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn1175","article-title":"Localized striatal delivery of GDNF as a treatment for Parkinson disease","volume":"7","author":"Kirik","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/10430340252837206","article-title":"Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra","volume":"13","author":"Klein","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0185","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ymthe.2005.10.008","article-title":"Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins","volume":"13","author":"Klein","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"Koprich","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0195","doi-asserted-by":"crossref","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"Koprich","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2009.12.009","article-title":"Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain","volume":"222","author":"Kornum","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0215","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0220","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0225","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","article-title":"Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein","volume":"13","author":"Lauwers","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0230","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0235","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/mds.23012","article-title":"Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease","volume":"25","author":"Li","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0245","doi-asserted-by":"crossref","unstructured":"Lindgren, H.S., Dunnett, S.B., accepted for publication. Cognitive dysfunction and depression in Parkinson's disease \u2014 What can be learned from rodent models? Eur. J. Neurosci. 35(12), 1894-907.","DOI":"10.1111\/j.1460-9568.2012.08162.x"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0240","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","article-title":"l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia","volume":"112","author":"Lindgren","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0250","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1006\/bbrc.1999.0954","article-title":"Is green fluorescent protein toxic to the living cells?","volume":"260","author":"Liu","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0260","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"alpha\u2010Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2004.06.008","article-title":"Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease","volume":"17","author":"Lo Bianco","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0265","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease","volume":"101","author":"Lo Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0275","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(03)00295-7","article-title":"Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation","volume":"343","author":"Maeda","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","article-title":"Genetic mouse models of Parkinson's disease: the state of the art","volume":"184","author":"Magen","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0290","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/syn.21543","article-title":"Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease","volume":"66","author":"Maia","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0295","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nbd.2006.04.007","article-title":"Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression","volume":"23","author":"Maingay","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2007.06.019","article-title":"rAAV-Mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease","volume":"207","author":"Manfredsson","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2990.1983.tb00320.x","article-title":"Pathological basis for neurotransmitter changes in Parkinson's disease","volume":"9","author":"Mann","year":"1983","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0310","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.57.6.672","article-title":"Parkinson's disease","volume":"57","author":"Marsden","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0315","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","article-title":"Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2012.05.022_bb0320","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0325","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0330","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0335","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0340","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2990.1993.tb00480.x","article-title":"A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease","volume":"19","author":"Patt","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01250009","article-title":"Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA","volume":"59","author":"Reader","year":"1984","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2007.11.002","article-title":"Generation of a alpha-synuclein-based rat model of Parkinson's disease","volume":"30","author":"Recchia","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/archneurol.2011.2675","article-title":"Relationship between mitochondria and alpha-synuclein: a study of single substantia nigra neurons","volume":"69","author":"Reeve","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0360","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1460-9568.1999.00566.x","article-title":"Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle","volume":"11","author":"Rosenblad","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0365","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1523\/JNEUROSCI.22-24-10690.2002","article-title":"Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease","volume":"22","author":"Ryu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0370","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0375","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0380","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, Parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0385","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/msj.20303","article-title":"Mitochondrial pathology in Parkinson's disease","volume":"78","author":"Schapira","year":"2011","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0395","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.neurobiolaging.2008.11.010","article-title":"Selective noradrenergic vulnerability in alpha-synuclein transgenic mice","volume":"31","author":"Sotiriou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0400","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0405","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra","volume":"100","author":"St Martin","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0410","first-page":"193","article-title":"Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats","volume":"32","author":"Strome","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0415","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","article-title":"Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease","volume":"67","author":"Theodore","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of alpha-synuclein as a progressive model of Parkinson's disease","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0425","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","article-title":"Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice","volume":"21","author":"Unger","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0430","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0435","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.20-16-06021.2000","article-title":"Neuropathology in mice expressing human alpha-synuclein","volume":"20","author":"van der Putten","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0440","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","article-title":"Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease","volume":"14","author":"Vercammen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0445","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.neuroscience.2010.12.005","article-title":"Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat","volume":"175","author":"Walsh","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.05.022_bb0450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"l-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson's disease: relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0455","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2012.07769.x","article-title":"alpha-Synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease","author":"Xie","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0460","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"Yamada","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0465","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","article-title":"Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease","volume":"16","author":"Yamada","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2012.05.022_bb0475","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0006-8993(91)90553-8","article-title":"Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain","volume":"556","author":"Zhou","year":"1991","journal-title":"Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612002336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612002336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T14:58:08Z","timestamp":1714057088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612002336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0014488612002336"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.05.022","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}